Filing Details
- Accession Number:
- 0001127602-24-012710
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-04-09 16:25:25
- Reporting Period:
- 2024-04-08
- Accepted Time:
- 2024-04-09 16:25:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1492422 | Apellis Pharmaceuticals Inc. | APLS | Pharmaceutical Preparations (2834) | 271537290 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1657720 | Pascal Deschatelets | C/O Apellis Pharmaceuticals, Inc. 100 Fifth Avenue, 3Rd Floor Waltham MA 02451 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-04-08 | 69,107 | $3.76 | 1,185,090 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-04-08 | 64,379 | $54.12 | 1,120,711 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-08 | 4,728 | $54.92 | 1,115,983 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-04-08 | 69,107 | $0.00 | 69,107 | $3.76 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 37,280 | 2026-02-07 | No | 4 | M | Direct |
Footnotes
- This is a scheduled exercise & sale from 10b5-1 trading plan dated 12/8/2023.
- This is a scheduled exercise & sale from 10b5-1 trading plan dated 12/8/2023.
- This transaction was executed in multiple trades at prices ranging from $53.770 - $54.765. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $54.775 - $55.750. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This stock option was granted on 02/08/2016 and is fully vested.
Billionaire Hedge Funds
